Administration of NMN ameliorated amyloid-induced synaptic loss and dysfunction, and reversed cognitive impairments in AD-Tg mice, including severe impairment of spatial learning, spatial memory and contextual memory. This evidence concerns the gene NTS and Alzheimer disease.